Guided Therapeutics (GTHP) Revenue Growth (1y) (2011 - 2025)
Guided Therapeutics (GTHP) Revenue Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.47 Bn | 176.17 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 129.01 Bn | 126.14 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 68.46 Bn | 67.01 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 48.40 Bn | 44.73 Bn | 1.29 Bn | 16.70% |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn | 15.05% |
| 7 | GE HealthCare Technologies | 28.36 Bn | 26.07 Bn | 1.98 Bn | 7.41% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.46 Bn | 22.33 Bn | 2.07 Bn | 6.08% |
| 10 | Guided Therapeutics | 20.39 Mn | 20.32 Mn | 458,000.00 | 58,900.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 58,900.00% |
| Dec 31, 2024 | -96.88% |
| Mar 31, 2024 | -72.73% |
| Jun 30, 2023 | 780.00% |
| Mar 31, 2023 | 340.00% |
| Sep 30, 2022 | -84.21% |
| Jun 30, 2022 | 150.00% |
| Dec 31, 2021 | 140.00% |
| Sep 30, 2021 | -75.32% |
| Dec 31, 2020 | 56.25% |
| Sep 30, 2020 | 7,600.00% |
| Dec 31, 2019 | -61.90% |
| Sep 30, 2019 | -50.00% |
| Jun 30, 2019 | -87.50% |
| Mar 31, 2019 | 350.00% |
| Dec 31, 2018 | -60.75% |
| Sep 30, 2018 | -93.94% |
| Jun 30, 2018 | -90.80% |
| Mar 31, 2018 | -80.95% |
| Dec 31, 2017 | 122.02% |